![Natalia Badillo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Natalia Badillo
Finanzdirektor/CFO bei Friede & Goldman Ltd.
Profil
Natalia Badillo is currently the Chief Financial Officer at Friede & Goldman Ltd.
since 2008.
Prior to this, she worked as a Finance Director at Janssen-Cilag International NV.
She holds an MBA from INSEAD.
Aktive Positionen von Natalia Badillo
Unternehmen | Position | Beginn |
---|---|---|
Friede & Goldman Ltd.
![]() Friede & Goldman Ltd. Contract DrillingIndustrial Services Friede & Goldman Ltd. designs and manufactures mobile offshore drilling and production units. It offers naval architects and marine engineering services. The company was founded by Vladimir M. Friede and Jerome L. Goldman and is headquartered in Houston, TX. | Finanzdirektor/CFO | 04.08.2009 |
Ehemalige bekannte Positionen von Natalia Badillo
Unternehmen | Position | Ende |
---|---|---|
Janssen-Cilag International NV
![]() Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Finanzdirektor/CFO | - |
Ausbildung von Natalia Badillo
INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Friede & Goldman Ltd.
![]() Friede & Goldman Ltd. Contract DrillingIndustrial Services Friede & Goldman Ltd. designs and manufactures mobile offshore drilling and production units. It offers naval architects and marine engineering services. The company was founded by Vladimir M. Friede and Jerome L. Goldman and is headquartered in Houston, TX. | Industrial Services |
Janssen-Cilag International NV
![]() Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Health Technology |